Healthcare is necessary and vital to the longevity of our population. Countries with the resources to provide advanced healthcare have opted for a multitude of systems for providing care. This paper will examine the price of one drug (insulin) and what it demonstrates about the United States healthcare system. It will further present healthcare and the access to safe treatment as a human right, one which has been repeatedly trespassed for profit by the largest companies. The tactics taken by these companies, all through legal routes, prioritize profit over people. It ensures a lower quality of care and a suppression of new drug research. Insulin is a demonstrative drug for the state of healthcare in the United State. Its widespread use affects access to care and costs can be easily compared to prices in other developed countries. Although not the only drug with exorbitant prices, insulin pricing is an example of a troubling trend in healthcare.